VELCADE® receives positive regulatory recommendation in the European Union for subcutaneous administration
26 June 2012 | By Janssen-Cilag International NV
New route of administration provides improved safety and greater convenience...
List view / Grid view
News
Bristol-Myers Squibb & Pfizer receive response from FDA for ELIQUIS® (apixaban)
26 June 2012 | By Bristol-Myers Squibb Company / Pfizer
Additional information requested from ARISTOTLE trial results...
PerkinElmer announces OneSource® Scientific IT Services to drive laboratory productivity growth
25 June 2012 | By Edelman (On behalf of PerkinElmer, Inc.)
PerkinElmer, Inc., has unveiled its OneSource® Scientific IT Services...
IDBS ELN powers world class preclinical research at the University of Cape Town
IDBS, a global provider of innovative data management, analytics and modeling solutions, have announced that the University of Cape Town (UCT) Drug Discovery and Development Centre, H3-D (http://www.h3-d.uct.ac.za/), is using the BioBook Electronic Laboratory Notebook (ELN) to store, manage and analyze its Drug Metabolism and Pharmacokinetic (DMPK) data. Aligning itself…
Abbott receives positive opinion for HUMIRA® in non-radiographic axial spondyloarthritis from EMA’s CHMP
25 June 2012 | By Abbott
Abbott announced that the CHMP has issued a positive opinion for HUMIRA®...
Sanofi Pasteur’s 6-in-1 pediatric vaccine Hexaxim™ receives positive opinion from EMA
22 June 2012 | By Sanofi Pasteur
Sanofi Pasteur, announced that HexaximTM received a positive scientific opinion...
New data from Phase III study showed that people with HER2-positive metastatic breast cancer lived longer with Perjeta
22 June 2012 | By Roche
“We are pleased that Perjeta helped people with HER2-positive metastatic breast cancer..."
Novartis receives positive CHMP opinion for once-daily Seebri® Breezhaler® to treat COPD patients in the EU
22 June 2012 | By Novartis
CHMP has adopted a positive opinion for Seebri® Breezhaler®...
CHMP recommends Novartis drug Afinitor® for EU approval marking major milestone in the treatment of advanced breast cancer
22 June 2012 | By Novartis
Positive opinion for Afinitor® tablets...
Zinforo receives positive CHMP opinion in the European Union for the treatment of patients with serious skin infections or community acquired pneumonia
22 June 2012 | By AstraZeneca
Zinforo receives positive CHMP opinion...
Bristol-Myers Squibb and Emory University announce partnership
21 June 2012 | By Bristol-Myers Squibb Company
First studies under the agreement to focus on clinical trial programs in oncology...
Catalent and Bend Research partner to provide integrated solutions for oral controlled-release technologies
21 June 2012 | By Catalent Pharma Solutions
Catalent Pharma Solutions and Bend Research have entered into an agreement...
Glythera relocates to North East as part of £2M funding round
21 June 2012 | By kdm communications limited
Glythera has secured a fundraising round totalling £2M with IP Group, which will be tranched over the next three years...
Novo Nordisk to initiate phase 3 development of semaglutide
21 June 2012 | By Novo Nordisk
The decision to initiate the global phase 3 development programme for semaglutide announced...
Novo Nordisk puts health on the agenda in Rio
20 June 2012 | By Novo Nordisk
Novo Nordisk is hosting a side-event during the UN conference, Rio+20, on sustainable development...
